secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001437749-26-002682
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals appoints Joseph M. Casper as COO; base salary $250,000 plus options
--------------------------------------------------------------------------------

- Joseph M. Casper appointed Chief Operating Officer effective January 27, 2026.
- Casper has 35 years of healthcare experience including Deloitte, Kaiser Permanente, and Anthem.
- Annual base salary of $250,000 with a bonus of 25% subject to milestones with CEO.
- Granted 100,000 options: 33.3% vest June 1, 2026, 33.3% Dec 1, 2026, 33.3% Dec 1, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926002682/0001437749-26-002682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774926002682/nrxp20260202_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-002682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer